CSIMarket
 
Pavmed Inc   (PAVM)
 

The Medical Equipment & Supplies company reported devastating Revenues slide, over the most recent fiscal period

Pavmed Inc delivered fourth quarter of 2022 operating shortfall of $-24.677 millions


Published Mar 27 2023
Goran Soko / CSIMarket.com Contributer


Medical_ultrasound_examination_pdFor the fourth quarter of 2022 earnings season company decreased a loss per share of $-0.21 per share compare to $-0.24 a year before and EPS improved from $-0.29 per share from the preceding quarter.

Revenues dropped sharply by -62.667 % to $0.11 millions from $0.30 millions in the corresponding quarter a year before and sequentially Revenues surged by 47.368 % from $0.08 millions.




For the fourth quarter of 2022 earnings season Pavmed Inc realized net loss of $-24.572 million, larger than $-19.678 million a year ago.

PAVM announced loss of $-103.24 millions and Revenues of $0.38 millions in the financial period 2022.

Net loss per share has widen to $-1.00 from $-0.65 in preceding financial year, while Revenues fell by -24.6 % from $0.50 millions a year before.

Pavmed Inc is expected to report next financial recent numbers on April 04, 2023.



Pavmed Inc's Inventory Turnover Ratio

Pavmed Inc's Net Profit Margin



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071